• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Increased incidence of advanced breast cancer found in young women

bys25qthea
February 26, 2013
in Chronic Disease, Oncology
Reading Time: 4 mins read
Share on FacebookShare on Twitter

Feb 26th – The incidence of advanced breast cancer in women ages 25-39 has increased from 1.53/100,00 in 1976 to 2.90/100,000 in 2009.

[tabs tab1=”2MM Rundown” tab2= “2MM Full Report”]

[tab]

Image: PD

1. The incidence of advanced breast cancer in women ages 25-39 has increased from 1.53/100,00 in 1976 to 2.90/100,000 in 2009.

RELATED REPORTS

Daraxonrasib extends survival in metastatic pancreatic cancer

Molecularly guided therapy may improve outcomes in patients with unfavourable cancer of unknown primary compared with standard chemotherapy

2 Minute Medicine Rewind September 7, 2026

2. The increase was statistically significant in African American and non-Hispanic white populations.

This retrospective study found the incidence of advanced breast cancer in women ages 25-39 has increased from 1.53/100,00 in 1976 to 2.90/100,000 in 2009. Of note, 7% of women with breast cancer are diagnosed before age 40 and survival is inversely proportional to age. While the incidence of breast cancer with distant disease is increasing in this age group, the authors also argue that this growth is also accelerating as evidenced by the increasing average compound increases, decreasing doubling times, and steeper regression lines in successive SEER registries.

Although women under 40 represent a small percentage of those diagnosed each year, they are more likely to be diagnosed with a more advanced stage breast cancer, have a worse prognosis, the least health insurance, and most years of life ahead of them, possibly suggesting the utility of some type of screening in this population. If the results of this retrospective study are corroborated in future studies, investigation into potential causes and possible interventions would certainly be warranted.

Click to read the study in JAMA

[/tab]

[tab]

Image: PD

1. The incidence of advanced breast cancer in women ages 25-39 has increased from 1.53/100,00 in 1976 to 2.90/100,000 in 2009. 

2. The increase was statistically in African American and non-Hispanic white populations.

This [retrospective] study: This retrospective study was conducted to examine the breast cancer incidence, trends, and survival rates as a function of age and extent of disease at diagnosis. The data used was collected from 3 U.S. National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) registries (1973-2009, 1992-2009, and 2000-2009). The incidence of advanced breast cancer in women ages 25-39 has increased from 1.53/100,00 in 1976 to 2.90/100,000 in 2009 representing an average compound increase of 2.07%/year. This magnitude of increase was not evident in any other age group. There was no change in the incidence of localized or regional disease in this age group. The increase in incidence was evident among all races and ethnicities but was statistically significant in African American and non-Hispanic white populations. The incidence of estrogen receptor-positive subtypes increased more than estrogen-negative subtypes.

In sum: This retrospective study found the incidence of advanced breast cancer in women ages 25-39 has increased from 1.53/100,00 in 1976 to 2.90/100,000 in 2009. Of note, 7% of women with breast cancer are diagnosed before age 40 and survival is inversely proportional to age. With no standardized screening recommendations for women less than 40 years of age, it may be hypothesized that cancers discovered in this cohort are more likely to be late stage. While the incidence is increasing, the authors also make an argument that this growth is also accelerating as evidenced by the increasing average compound increases, decreasing doubling times, and steeper regression lines in successive SEER registries. This is certainly epidemiologically and clinically significant.

Although women under 40 represent a small percentage of those diagnosed each year, they are more likely to be diagnosed with a more advanced stage breast cancer, have a worse prognosis, the least health insurance, and most years of life ahead of them, possibly suggesting the utility of standardized screening in this population. If the results of this retrospective study are corroborated in future studies, investigation into potential causes and possible interventions would certainly be warranted.

Click to read the study in JAMA

By Brittany Hasty and Rif Rahman

More from this author: Increasing malaria prophylaxis doses in pregnancy associated with decrease in low birth weight infants, More patients utilizing hospice services and choosing to die at home over past decade, Early antiretroviral therapy in HIV infection is associated with increased likelihood of CD4+ recovery

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain.

[/tab]

[/tabs]

Tags: advanced breast cancerBreast CanceroncologySEER
Previous Post

Mediterranean diet may reduce risk of cardiovascular disease

Next Post

No reduction in complications after restricting bariatric surgery to centers of excellence

RelatedReports

Oncology

Daraxonrasib extends survival in metastatic pancreatic cancer

September 17, 2026
Quick Take: Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening
Chronic Disease

Molecularly guided therapy may improve outcomes in patients with unfavourable cancer of unknown primary compared with standard chemotherapy

September 7, 2026
Long-term outcomes for off-pump and on-pump CABG are similar
Weekly Rewinds

2 Minute Medicine Rewind September 7, 2026

September 7, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026
Next Post

No reduction in complications after restricting bariatric surgery to centers of excellence

Aneurysm diameter useful in determining frequency of surveillance

Omalizumab relieves symptoms in chronic idiopathic urticaria

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.